A Biomarker Study to Predict Treatment Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma

Clinical trial NCT07063758 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07063758
Sponsor: National Taiwan University Clinical Trial Center
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Advanced Urothelial Carcinoma

Start date: 2025-04-01
Primary completion: 2029-09-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.